Global Gene Therapies for Tumor Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030
1 Market Overview
- 1.1 Product Overview and Scope of Gene Therapies for Tumor Treatment
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Gene Therapies for Tumor Treatment by Type
- 1.3.1 Overview: Global Gene Therapies for Tumor Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Gene Therapies for Tumor Treatment Consumption Value Market Share by Type in 2023
- 1.3.3 Gene Induced Immunotherapy
- 1.3.4 Oncolytic Virotherapy
- 1.3.5 Gene Transfer
- 1.4 Global Gene Therapies for Tumor Treatment Market by Application
- 1.4.1 Overview: Global Gene Therapies for Tumor Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Other
- 1.5 Global Gene Therapies for Tumor Treatment Market Size & Forecast
- 1.6 Global Gene Therapies for Tumor Treatment Market Size and Forecast by Region
- 1.6.1 Global Gene Therapies for Tumor Treatment Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Gene Therapies for Tumor Treatment Market Size by Region, (2019-2030)
- 1.6.3 North America Gene Therapies for Tumor Treatment Market Size and Prospect (2019-2030)
- 1.6.4 Europe Gene Therapies for Tumor Treatment Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Gene Therapies for Tumor Treatment Market Size and Prospect (2019-2030)
- 1.6.6 South America Gene Therapies for Tumor Treatment Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Gene Therapies for Tumor Treatment Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Novartis
- 2.1.1 Novartis Details
- 2.1.2 Novartis Major Business
- 2.1.3 Novartis Gene Therapies for Tumor Treatment Product and Solutions
- 2.1.4 Novartis Gene Therapies for Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Novartis Recent Developments and Future Plans
- 2.2 Gilead Sciences
- 2.2.1 Gilead Sciences Details
- 2.2.2 Gilead Sciences Major Business
- 2.2.3 Gilead Sciences Gene Therapies for Tumor Treatment Product and Solutions
- 2.2.4 Gilead Sciences Gene Therapies for Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Gilead Sciences Recent Developments and Future Plans
- 2.3 Amgen
- 2.3.1 Amgen Details
- 2.3.2 Amgen Major Business
- 2.3.3 Amgen Gene Therapies for Tumor Treatment Product and Solutions
- 2.3.4 Amgen Gene Therapies for Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Amgen Recent Developments and Future Plans
- 2.4 Shanghai Sunway
- 2.4.1 Shanghai Sunway Details
- 2.4.2 Shanghai Sunway Major Business
- 2.4.3 Shanghai Sunway Gene Therapies for Tumor Treatment Product and Solutions
- 2.4.4 Shanghai Sunway Gene Therapies for Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Shanghai Sunway Recent Developments and Future Plans
- 2.5 Sibiono
- 2.5.1 Sibiono Details
- 2.5.2 Sibiono Major Business
- 2.5.3 Sibiono Gene Therapies for Tumor Treatment Product and Solutions
- 2.5.4 Sibiono Gene Therapies for Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Sibiono Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Gene Therapies for Tumor Treatment Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Gene Therapies for Tumor Treatment by Company Revenue
- 3.2.2 Top 3 Gene Therapies for Tumor Treatment Players Market Share in 2023
- 3.2.3 Top 6 Gene Therapies for Tumor Treatment Players Market Share in 2023
- 3.3 Gene Therapies for Tumor Treatment Market: Overall Company Footprint Analysis
- 3.3.1 Gene Therapies for Tumor Treatment Market: Region Footprint
- 3.3.2 Gene Therapies for Tumor Treatment Market: Company Product Type Footprint
- 3.3.3 Gene Therapies for Tumor Treatment Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Gene Therapies for Tumor Treatment Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Gene Therapies for Tumor Treatment Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Gene Therapies for Tumor Treatment Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Gene Therapies for Tumor Treatment Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Gene Therapies for Tumor Treatment Consumption Value by Type (2019-2030)
- 6.2 North America Gene Therapies for Tumor Treatment Consumption Value by Application (2019-2030)
- 6.3 North America Gene Therapies for Tumor Treatment Market Size by Country
- 6.3.1 North America Gene Therapies for Tumor Treatment Consumption Value by Country (2019-2030)
- 6.3.2 United States Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
- 6.3.3 Canada Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Gene Therapies for Tumor Treatment Consumption Value by Type (2019-2030)
- 7.2 Europe Gene Therapies for Tumor Treatment Consumption Value by Application (2019-2030)
- 7.3 Europe Gene Therapies for Tumor Treatment Market Size by Country
- 7.3.1 Europe Gene Therapies for Tumor Treatment Consumption Value by Country (2019-2030)
- 7.3.2 Germany Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
- 7.3.3 France Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
- 7.3.5 Russia Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
- 7.3.6 Italy Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Gene Therapies for Tumor Treatment Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Gene Therapies for Tumor Treatment Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Gene Therapies for Tumor Treatment Market Size by Region
- 8.3.1 Asia-Pacific Gene Therapies for Tumor Treatment Consumption Value by Region (2019-2030)
- 8.3.2 China Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
- 8.3.3 Japan Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
- 8.3.5 India Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
- 8.3.7 Australia Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Gene Therapies for Tumor Treatment Consumption Value by Type (2019-2030)
- 9.2 South America Gene Therapies for Tumor Treatment Consumption Value by Application (2019-2030)
- 9.3 South America Gene Therapies for Tumor Treatment Market Size by Country
- 9.3.1 South America Gene Therapies for Tumor Treatment Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Gene Therapies for Tumor Treatment Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Gene Therapies for Tumor Treatment Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country
- 10.3.1 Middle East & Africa Gene Therapies for Tumor Treatment Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
- 10.3.4 UAE Gene Therapies for Tumor Treatment Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Gene Therapies for Tumor Treatment Market Drivers
- 11.2 Gene Therapies for Tumor Treatment Market Restraints
- 11.3 Gene Therapies for Tumor Treatment Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Gene Therapies for Tumor Treatment Industry Chain
- 12.2 Gene Therapies for Tumor Treatment Upstream Analysis
- 12.3 Gene Therapies for Tumor Treatment Midstream Analysis
- 12.4 Gene Therapies for Tumor Treatment Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Gene Therapies for Tumor Treatment market size was valued at USD 5057.3 million in 2023 and is forecast to a readjusted size of USD 17330 million by 2030 with a CAGR of 19.2% during review period.
Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.
The gene therapies for tumor treatment market is driven by the growing need for targeted and personalized cancer therapies and the increasing focus on innovative treatment approaches. Gene therapies involve the introduction of therapeutic genes into cancer cells to target and destroy tumors or inhibit their growth. The rise in the incidence of cancer and the limitations of conventional cancer treatments contribute to market growth. Moreover, advancements in gene editing technology and the understanding of tumor genetics have improved the development of effective gene therapies. However, the market also faces challenges, including the complexity of tumor heterogeneity and the potential for off-target effects in gene editing. Additionally, addressing regulatory and ethical considerations and ensuring accessibility and affordability can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer safe and efficient gene therapies, collaborate with oncology centers to conduct clinical trials and address specific tumor types, and address the challenges to meet the increasing demand for effective and transformative cancer treatments.
The Global Info Research report includes an overview of the development of the Gene Therapies for Tumor Treatment industry chain, the market status of Hospital (Gene Induced Immunotherapy, Oncolytic Virotherapy), Clinic (Gene Induced Immunotherapy, Oncolytic Virotherapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gene Therapies for Tumor Treatment.
Regionally, the report analyzes the Gene Therapies for Tumor Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gene Therapies for Tumor Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Gene Therapies for Tumor Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gene Therapies for Tumor Treatment industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Gene Induced Immunotherapy, Oncolytic Virotherapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gene Therapies for Tumor Treatment market.
Regional Analysis: The report involves examining the Gene Therapies for Tumor Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gene Therapies for Tumor Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Gene Therapies for Tumor Treatment:
Company Analysis: Report covers individual Gene Therapies for Tumor Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gene Therapies for Tumor Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Gene Therapies for Tumor Treatment. It assesses the current state, advancements, and potential future developments in Gene Therapies for Tumor Treatment areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gene Therapies for Tumor Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Gene Therapies for Tumor Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer
Market segment by Application
Hospital
Clinic
Other
Market segment by players, this report covers
Novartis
Gilead Sciences
Amgen
Shanghai Sunway
Sibiono
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Therapies for Tumor Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Therapies for Tumor Treatment, with revenue, gross margin and global market share of Gene Therapies for Tumor Treatment from 2019 to 2024.
Chapter 3, the Gene Therapies for Tumor Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gene Therapies for Tumor Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Therapies for Tumor Treatment.
Chapter 13, to describe Gene Therapies for Tumor Treatment research findings and conclusion.